Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 6:43 PM
Ignite Modification Date: 2025-12-24 @ 6:43 PM
NCT ID: NCT05793957
Eligibility Criteria: Inclusion Criteria: * English speaking: Ability to interact with virtual reality content may be impacted by inability to understand English; moreover, paper questionnaires will only be provided in English. * Older than 18 years of age, and younger than 89 years of age. All sexes/gender identities and members of all races and ethnic groups will be included. * Planned to receive chemotherapy infusion for head and neck, breast, thoracic, and hematologic cancers at the Oregon Health \& Science University (OHSU) South Waterfront Center for Health \& Healing building 2 (there are no restrictions related to prior chemotherapy infusions or other cancer treatments). * Chemotherapy treatment lasting at least 10 minutes. * Ability to understand and willingness to sign a written informed consent document. Exclusion Criteria: * Social or psychiatric conditions that may interfere with compliance. * Reconstruction, incisions, wounds, wound care, or injury that impact the ability to place on the VR headset. This would limit the ability to utilize the VR headset. * History of seizure or epilepsy. * History of vertigo or persistent dizziness. * Use of cardiac pacemaker, requirement for hearing aid on at all times, or have defibrillators. * Children. * Pregnant women. * Decisionally impaired adults. * Prisoners.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 89 Years
Study: NCT05793957
Study Brief:
Protocol Section: NCT05793957